Table 2.
Univariate analysis of predictors of in-hospital mortality for patients with ELVO.
| Variables | Discharged (n = 27) | Dead (n = 9) | P value |
|---|---|---|---|
| Age-yr., mean (SD) | 65.89 (13.52) | 68 (12.6) | 0.683 |
| Male sex, n (%) | 14 (51.9) | 4 (44.4) | 0.700 |
| Pulmonary symptoms, n (%) | 3 (11.1) | 6 (66.7) | 0.001 |
| Race | |||
| White, n (%) | 6 (22.2) | 2 (22.2) | 0.118 |
| African American, n (%) | 11 (40.7) | 1 (11.1) | |
| Hispanic, n (%) | 7 (25.9) | 6 (66.7) | |
| Other, n (%) | 3 (11.1) | 0 (0) | |
| Vascular risk factors | |||
| Hypertension, n (%) | 23 (85.2) | 4 (44.4) | 0.015 |
| Hyperlipidemia, n (%) | 13 (48.1) | 4 (44.4) | 0.847 |
| Diabetes, n (%) | 9 (33.3) | 5 (55.6) | 0.236 |
| Atrial fibrillation, n (%) | 5 (18.5) | 1 (11.1) | 0.606 |
| Congestive heart failure, n (%) | 3 (11.1) | 0 (0) | 0.296 |
| Smoking, n (%) | 1 (3.7) | 5 (55.6) | 0.003 |
| Clinical presentation | |||
| mRS baseline, median (IQR) | 0 (0–1) | 0 (0–2) | 0.747 |
| NIHSS on admission, median (IQR) | 15 (10–20) | 19 (17–20) | 0.117 |
| ASPECTS on admission, median (IQR) | 7 (4–8) | 6 (2–8) | 0.446 |
| Laboratory values on admission | |||
| White blood cell-count, median (IQR) per mm3 | 8.4 (5.7–10.7) | 8.7 (5.2–10.5) | 0.943 |
| Platelet-count, median (IQR) k per mm3 | 217 (188–256) | 220 (178–250) | 0.858 |
| Prothrombin time, median (IQR) sec | 13.9 (13.5–15.1) | 13.8 (13.5–15.6) | 0.827 |
| D-dimer, median (IQR) ng/ml | 1.51 (.50–8.86) | 20 (19.3–20) | 0.007 |
| Fibrinogen, median (IQR) | 420 (362–485) | 379.5 (137–696.5) | 0.914 |
| Ferritin, median (IQR) | 628 (119–691) | 2426 (1729–3075) | 0.006 |
| Blood urea nitrogen, median (IQR) | 14 (10–18) | 23 (11–26) | 0.312 |
| Creatinine, median (IQR) | 1.00 (.70–1.2) | .80 (.60–.90) | 0.032 |
| Location of occlusion | |||
| Right MCA, n (%) | 8 (29.6) | 2 (22.2) | 0.667 |
| Left MCA, n (%) | 11 (40.7) | 4 (44.4) | 0.845 |
| Right ICA (with carotid T), n (%) | 2 (7.4) | 0 (0) | 0.401 |
| Left ICA (with carotid T), n (%) | 0 (0) | 2 (22.2) | 0.012 |
| Right ICA, n (%) | 3 (11.1) | 1 (11.1) | 1.0 |
| Left ICA, n (%) | 3 (11.1) | 2 (22.2) | 0.404 |
| Basilar, n (%) | 1 (3.7) | 0 (0) | 0.558 |
| Other LVO (ACA, PCA, Vertebral) | 3 (11.1) | 2 (22.2) | 0.151 |
| Treatment information | |||
| Thrombolysis i.v, n (%) | 6 (22.2) | 2 (22.2) | 1.0 |
| Thrombectomy, n (%) | 9 (33.3) | 3 (33.3) | 1.0 |
| Time points | |||
| Emergency patients | |||
| Onset to first hospital, mins, median (IQR) | 342.5 (149–988) | 870 (161–1312) | 0.767 |
| Onset to our institution, mins, median (IQR) | 582 (245–1136) | 998 (235–1577) | 0.716 |
| >6hs from onset to door, n (%) | 15 (62.5) | 3 (60) | 0.917 |
| Thrombectomy patients | |||
| Door to groin, mins, median (IQR) | 84 (68–99) | 126 (69–134) | 0.373 |
| Groin to recanalization, mins, median (IQR) | 38 (31–56) | 60 (36–68) | 0.482 |
| TICI score ≥2b, n (%) | 9 (100) | 1 (33.3) | 0.007 |
| Day 1 NIHSS, median (IQR) | 11 (6–12) | 19 (1–23) | 0.482 |